Fig. 8
From: Identification and validation of platinum resistance signature in gastric cancer
Correlation between model genes and clinical variables. (A) IHC of characteristic genes including EZH2, SFRP4, E2F2, COL3A1, TMEM108, TNFAIP2, PDGFRA, SNAI1 and GLI1 in GC tumor and normal tissues from HPA database. (B) Gene expression of m6A regulators in two group samples. (C) The expression levels of m5C regulators in the two groups. (D) IFN-γ pathway markers in high and low drug resistance score samples. (E) ICB related gene expression levels in the two groups. *P < 0.05; **P < 0.01; ***P < 0.001